Ann Arbor, MI, United States of America

Richard H Bunge


Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 42(Granted Patents)


Location History:

  • Mt. Clemens, MI (US) (1983 - 1984)
  • Ann Arbor, MI (US) (1984 - 1988)

Company Filing History:


Years Active: 1983-1988

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Richard H. Bunge: Innovator in Antibiotic Compounds

Introduction

Richard H. Bunge is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of antimicrobial compounds, holding a total of 9 patents. His work focuses on the development of antibiotic compounds that exhibit both antimicrobial and antitumor properties.

Latest Patents

Among his latest patents is the CL-1957E antibiotic compound and its production. This invention involves a purified isolate of an actinomycete identified as ATCC 39366, which is capable of producing the antimicrobial compound CL-1957E. The compound is produced by cultivating isolate ATCC 39366 under aerobic conditions in a culture medium containing assimilable sources of carbon and nitrogen until a substantial quantity of the CL-1957E compound is produced. The patent also discloses methods for isolating the CL-1957E compound and its use in treating microbial infections and tumors in mammals.

Another significant patent is for the CL-1957D antibiotic compound and its production. Similar to CL-1957E, this compound is also derived from the actinomycete isolate ATCC 39366. The production process involves cultivating the isolate under aerobic conditions in a suitable culture medium until a substantial quantity of the CL-1957D compound is produced. This patent also includes pharmaceutical compositions comprising the CL-1957D compound and methods for treating microbial infections in mammals.

Career Highlights

Richard H. Bunge is associated with Warner-Lambert Company, where he has contributed to the advancement of pharmaceutical innovations. His work has been instrumental in developing new antibiotic compounds that have the potential to address significant health challenges.

Collaborations

Some of his notable coworkers include James C. French and Timothy R. Hurley. Their collaborative efforts have further enhanced the research and development of antimicrobial compounds.

Conclusion

Richard H. Bunge's innovative work in the field of antibiotic compounds has led to the development of significant pharmaceutical advancements. His contributions continue to impact the treatment of microbial infections and tumors, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…